Mr. Louis Laflamme reports

OPSENS TO HOST THIRD QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY JULY 13, 2023

Opsens Inc. will release financial results for its third quarter of fiscal year 2023, ended May 31, 2023, on Thursday, July 13, 2023, before the open of the market. The company has scheduled a conference call the same day, at 11 a.m. ET, to review the results.

Interested parties can access the conference call by dialling 1-833-756-0865 or 1-412-317-5754 or can listen by a live webcast, five to 10 minutes before the beginning of the conference call.

A replay will be available after the call, in the investors section of the company's website.

About Opsens Inc.

Opsens focuses mainly on cardiology. The company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fibre optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of more than 250,000 patients in more than 30 countries. It is approved for sale in the United States, the European Union, the United Kingdom, Japan and Canada.

Opsens has recently received Food and Drug Administration clearance and Health Canada approval to commercialize the SavvyWire for transcatheter aortic valve replacement procedures (TAVR). This unique guidewire is a three-in-one solution for stable aortic valve delivery and positioning, continuous accurate hemodynamic measurement during the procedure, and reliable left ventricular pacing without the need for adjunct devices or venous access.